CAS 507475-17-4
:2-(carbamoylamino)-5-(4-fluorophenyl)thiophene-3-carboxamide
Description:
2-(Carbamoylamino)-5-(4-fluorophenyl)thiophene-3-carboxamide, with the CAS number 507475-17-4, is a chemical compound characterized by its thiophene core, which is a five-membered heterocyclic ring containing sulfur. This compound features a carbamoylamino group and a carboxamide functional group, contributing to its potential as a bioactive molecule. The presence of a 4-fluorophenyl substituent enhances its lipophilicity and may influence its biological activity. The thiophene structure is known for its stability and ability to participate in various chemical reactions, making it a versatile scaffold in medicinal chemistry. This compound may exhibit properties such as anti-inflammatory or anticancer activities, although specific biological data would depend on empirical studies. Its solubility, melting point, and reactivity would be influenced by the functional groups present, which can also affect its pharmacokinetic properties. Overall, this compound represents a class of thiophene derivatives that are of interest in pharmaceutical research and development.
Formula:C12H10FN3O2S
InChI:InChI=1/C12H10FN3O2S/c13-7-3-1-6(2-4-7)9-5-8(10(14)17)11(19-9)16-12(15)18/h1-5H,(H2,14,17)(H3,15,16,18)
SMILES:c1cc(ccc1c1cc(C(=N)O)c(NC(=N)O)s1)F
Synonyms:- 2-((Aminocarbonyl)Amino)-5-(4-Fluorophenyl)-3-Thiophenecarboxamide
- 3-Thiophenecarboxamide, 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
TPCA-1
CAS:<p>TPCA-1 (TPCA1) is an effective and specific IKK-2 inhibitor (IC50: 17.9 nM); shows >22-fold selectivity over IKK-1 and >550-fold selectivity over others kinases</p>Formula:C12H10FN3O2SPurity:95.03% - 97.86%Color and Shape:SolidMolecular weight:279.29TPCA-1
CAS:<p>Applications TPCA-1 is a direct dual inhibitor for both IKKβ (IKK-2) and STAT3. It inhibits STAT3 phosphorylation, DNA binding, and transactivation in vivo. Synergistic treatment of TPCA-1 with tyrosine kinase inhibitors (TKIs) can potentially be a more effective method for treating cancers.<br>References Nan, J., et al.: Mol. Cancer Ther., 13, 617 (2014); Birrell, M.A., et al.: Am. J. Respir. Crit. Care Med., 172, 962 (2005); Birrell, M.A., et al.: Mol. Pharmacol., 69, 1791 (2006)<br></p>Formula:C12H10FN3O2SColor and Shape:Light Beige SolidMolecular weight:279.2901TPCA-1
CAS:<p>Inhibitor of NFκB and STAT3 transcription factor</p>Formula:C12H10FN3O2SPurity:Min. 95%Molecular weight:279.29 g/mol




